Post job

Spero Therapeutics overview

Industry
Medical Laboratory
Revenue
Headquarters
Employees
41
Founded in
Website
Organization type
Public
Social media
Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Spero's lead program addresses a novel target driving virulence and persistence of Pseudomonas Aeruginosa infections and other Gram-negative pathogens. The company was founded by Atlas Venture, with financing from SR One and the Partners Innovation Fund.
Based in Cambridge, MA, Spero Therapeutics is a small health care company with only 41 employees and an annual revenue of $48.0M.

Spero Therapeutics's mission statement

To deliver life-saving drugs to patients suffering from multidrug-resistant infections and rare diseases.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Spero Therapeutics employee reviews

Be the first to review!

Do you work at Spero Therapeutics?

Help job seekers learn about working at Spero Therapeutics

Job openings at Spero Therapeutics
43 positions

On this page

Be the first to review Spero Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Spero Therapeutics?

The team at Spero Therapeutics

  • The founders of Spero Therapeutics are Ankit Mahadevia M.d and Laurence Rahme.
  • The key people at Spero Therapeutics are Ankit Mahadevia M.d and Laurence Rahme.
Key people
Ankit Mahadevia M.d
Laurence Rahme

Rate the Spero Therapeutics' inclusivity.

Zippia waving zebra

Do you work at Spero Therapeutics?

Is Spero Therapeutics' workforce diverse and inclusive?

Spero Therapeutics financial performance

9.6
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Spero Therapeutics currently has 53.5M in revenue. Spero Therapeutics's most recent quarter produced 2.7m (q2'2023).

Spero Therapeutics annual revenue

$104M
$83M
$62M
$42M
$21M
$0
2019
2020
2021
2022
2023
2024

Are you an executive, HR leader, or brand manager at Spero Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Spero Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of Spero Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Spero Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Spero Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Spero Therapeutics. The data presented on this page does not represent the view of Spero Therapeutics and its employees or that of Zippia.

Spero Therapeutics may also be known as or be related to SPERO THERAPEUTICS, INC., Spero Therapeutics, Spero Therapeutics, Inc. and Spero Therapeutics, LLC.